文献速递衰弱、肌少症与跌倒认知障碍与谵妄

中年累积缺陷衰弱可预测老年人阿尔茨海默病相关血浆生物标志物

Midlife cumulative deficit frailty predicts Alzheimer's disease-related plasma biomarkers in older adults.
PubMed 文献 · Age Ageing · 2024-01-01

研究纳入1286名越南时代双胞胎衰老研究中的社区居住男性,在平均56、62、68岁时评估累积缺陷衰弱指数(FI,含37项)。结果显示衰弱使68岁前全因死亡风险翻倍(OR=2.44),且56岁和62岁FI可预测68岁血浆NfL、Aβ40、Aβ42等ADRD相关生物标志物水平;衰弱遗传影响占45-48%。

要点

  • 中年衰弱使68岁前全因死亡风险翻倍(OR=2.44)。
  • 56岁和62岁FI可预测68岁血浆NfL、Aβ40、Aβ42水平。
  • 衰弱遗传影响占45-48%,环境因素约占一半。

核心结论

  • 50多岁时的衰弱使68岁前死亡风险翻倍。
  • 衰弱与ADRD的关联机制可能通过神经退行性相关生物标志物实现。
  • 累积缺陷衰弱随年龄增加但保持中等遗传度,环境因素约占一半方差,早期干预可能降低ADRD风险。

研究设计与样本

  • 研究为越南时代双胞胎衰老研究中的1286名社区居住男性,基线无ADRD,平均年龄56、62、68岁。
  • 累积缺陷衰弱指数(FI)含37项,评估多个生理系统;68岁时检测血浆β-淀粉样蛋白(Aβ40、Aβ42)、总tau(t-tau)和神经丝轻链(NfL)。

主要发现

  • 衰弱使68岁前全因死亡风险翻倍(OR=2.44)。
  • 56岁FI显著预测68岁NfL(P=0.014)、Aβ40(P=0.001)和Aβ42(P=0.023),但不预测t-tau。
  • 62岁FI预测68岁所有生物标志物:NfL(P=0.023)、Aβ40(P=0.002)、Aβ42(P=0.001)和t-tau(P=0.001)。
  • 68岁FI与68岁NfL(P=0.027)、Aβ40(P<0.001)、Aβ42(P=0.001)和t-tau(P=0.003)水平相关。
  • 遗传影响占衰弱方差的45-48%,并显著贡献其11年间的稳定性。

临床怎么用

  • 中年期评估累积缺陷衰弱可能有助于识别ADRD和神经退行性生物标志物升高风险人群。
  • 针对中年衰弱的环境因素干预可能有助于降低后续ADRD风险。

局限性

  • 研究人群为越南时代双胞胎衰老研究中的社区居住男性,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The study explores whether frailty at midlife predicts mortality and levels of biomarkers associated with Alzheimer's disease and related dementias (ADRD) and neurodegeneration by early old age. We also examine the heritability of frailty across this age period. METHODS: Participants were 1,286 community-dwelling men from the Vietnam Era Twin Study of Aging at average ages 56, 62 and 68, all without ADRD at baseline. The cumulative deficit frailty index (FI) comprised 37 items assessing multiple physiological systems. Plasma biomarkers at age 68 included beta-amyloid (Aβ40, Aβ42), total tau (t-tau) and neurofilament light chain (NfL). RESULTS: Being frail doubled the risk of all-cause mortality by age 68 (OR = 2.44). Age 56 FI significantly predicted age 68 NfL (P = 0.014), Aβ40 (P = 0.001) and Aβ42 (P = 0.023), but not t-tau. Age 62 FI predicted all biomarkers at age 68: NfL (P = 0.023), Aβ40 (P = 0.002), Aβ42 (P = 0.001) and t-tau (P = 0.001). Age 68 FI scores were associated with age 68 levels of NfL (P = 0.027), Aβ40 (P < 0.001), Aβ42 (P = 0.001) and t-tau (P = 0.003). Genetic influences accounted for 45-48% of the variance in frailty and significantly contributed to its stability across 11 years. CONCLUSIONS: Frailty during one's 50s doubled the risk of mortality by age 68. A mechanism linking frailty and ADRD may be through its associations with biomarkers related to neurodegeneration. Cumulative deficit frailty increases with age but remains moderately heritable across the age range studied. With environmental factors accounting for about half of its variance, early interventions aimed at reducing frailty may help to reduce risk for ADRD.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Buchholz E, Gillespie NA, Hunt JF, et al. Midlife cumulative deficit frailty predicts Alzheimer's disease-related plasma biomarkers in older adults. Age Ageing. 2024. PMID: 38454901. doi:10.1093/ageing/afae028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。